A comprehensive view of Insulet Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Insulet receives CE mark approval for Abbott FreeStyle Libre 2 Plus sensor compatibility with Omnipod 5 Automated Insulin Delivery System for type 1 diabetics; company planning a phased launch starting in UK and Netherlands in 2024
Published: February 07, 2024 by Associated Press
Baird: Early data suggest GLP-1 weight-loss drugs like Ozempic can drive type-2 diabetes into remission; if fewer patients need an insulin pump to put insulin into the body, companies like Tandem Diabetes Care and Insulet could be hit hard
Published: October 18, 2023 by Business Insider
FDA clears Insulet's Omnipod GO, a tubeless, waterproof wearable insulin delivery device for adults with type 2 diabetes; device offers an alternative to daily injections and helps patients transition to insulin therapy
Published: April 28, 2023 by Drug Topics

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count